for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

Similar documents
MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

Erectile Dysfunction Medical Treatment

Managing Erectile Dysfunction

MALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara

Erectile Dysfunction; It s Not Just About Sex

IC351 (tadalafil, Cialis): update on clinical experience

Evidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Erectile Dysfunction: A Primer for Primary Care Providers

SEXUAL HEALTH. Erectile Dysfunction

ERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012

About Erectile Dysfunction. Causes, self-test and treatment

Diagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist

REVIEW Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link

Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction

Phosphodiesterase Type 5 Inhibitors Quantity Limit Program Summary

, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001

TADALAFIL THERAPY IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: RANDOMIZED, CONTROLLED TRIAL

Managing the Patient with Erectile Dysfunction: What Would You Do?

Dipartimento Ostetricia, Ginecologia, Urologia - Clinica Urologica Università di Napoli Federico II, Italy; 2

ORIGINAL ARTICLE. Keywords: doxazosin GITS; erectile dysfunction; IPSS; lower urinary tract symptoms; quality of life; sildenafil

/02/ /0 Vol. 168, , October 2002 THE JOURNAL OF UROLOGY

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

JMSCR Vol 05 Issue 07 Page July 2017

Alpha antagonists from initial concept to routine clinical practice

Patient Information ERECTILE DYSFUNCTION. Department of Urology

Sexual dysfunction in male LUTS. M. Gacci Department of Urology, University of Florence

The effect of sildenafil on electrostimulation-induced erection in the rat model

김준철 가톨릭대학교의과대학비뇨기과학교실

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

MANAGEMENT UPDATE , LLC MedReviews

Erectile dysfunction: unmet needs

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

ERECTILE DYSFUNCTION TREATMENTS

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

Schemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i

GUIDELINES ON ERECTILE DYSFUNCTION

Jan Farrell Nurse Consultant Urological Services Department of Urology Rotherham General Hospital NHS FT

I N T I M A C Y A N D S E X U A L I T Y I N L A T E R L I F E

National Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015

Effects of Isosorbide Dinitrate on the Urinary Flow Rate in Patients With Benign Prostatic Hyperplasia

Quality of life issues after treatment for prostate cancer

Erectile dysfunction Simply explained

13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Management of Post-Prostatectomy Urinary Incontinence and Sexual Dysfunction

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid

ED treatments: PDE5 inhibitors, injections and vacuum devices

Moving Beyond Cancer To A New Normal in Intimacy For Men & Their Partners. Presented by Mary Ellen West, RN, MN, CNM AASECT Certified Sex Counselor

Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction

Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several

Cialis. Cialis (tadalafil) Description

MEN NEED GOOD TOOLS. Men Need Good Tools. power, performance, price.

Erectile Dysfunction (Impotence)

Erectile Dysfunction Prior Authorization with Quantity Limit Criteria Program Summary

A review of phosphodiesterase type 5 inhibitors

Jan Farrell. Nurse Consultant Urology Department of Urology Rotherham General Hospital NHS FT

Erectile Dysfunction Case Study 2. Medical Student Case-Based Learning

THE FACTS ABOUT MEN S SEXUAL HEALTH

ERECTILE DYSFUNCTION DIAGNOSIS

Cialis. Cialis (tadalafil) Description

Erectile Dysfunction and the Prostate Cancer Patient

Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Clinic for urology, pediatric urology and andrology. Penile diseases. Dr. Arne Hauptmann

Testosterone and PDE5 inhibitors in the aging male

Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men?

Questions & Answers about Sexuality and Intimacy after Bladder Cancer. Part III: Causes and Treatments for Sexual Dysfunction

GUIDELINES ON ERECTILE DYSFUNCTION

Association of BPH with OAB: The Plumbing or the Pump?

european urology 53 (2008)

THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION

Sexual Function for Men with Spinal Cord Injury

Single Technology Appraisal (STA) Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia

Opinion: Yes. PDE-5 inhibitors should be used post radical prostatectomy as erection function rehabilitation?

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE. Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy

Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016

The Impact of Mental Illness on Sexual Dysfunction

Tobacco and Sex - What?

What is your specialty?

Medical Management of Erectile Dysfunction. Maarten Albersen MD PhD University Hospitals Leuven,

A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia

Tadalafil: a novel treatment for erectile dysfunction

Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation

GUIDELINES ON PRIAPISM

Sexual impotence. the forgotten complication

INTRODUCTION MISCELLANEOUS

BPH: a present and future perspective on health impact

A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction

Daily vs. on-demand PDE-5 inhibitors for management of erectile dysfunction following treatment for prostate cancer

Male Pelvic Health following Pelvic Surgery

The Centre for Men s Health

MODULE 4: ERECTILE DYSFUNCTION

Erectile dysfunction (ED) is the inability to obtain or maintain an erection satisfactory

aviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy

Transcription:

Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

Why this conference? Not promotional but educational The pharmacist regularly encounters patients who have been prescribed BPH/LUTS medications. The pharmacist regularly encounters patients who have been prescribed erectile dysfunction medications. The pharmacist regularly encounters patients who have been prescribed medications for the two conditions. The pharmacist have to know the rationale for the use of these medications prescribed very frequently and should be ready to answer patients questions. The pharmacist should be aware about any new indication such as Tadalafil 5mg daily for LUTS and ED.

Answers to common questions What is erectile dysfunction (ED)? What is «Lower urinary tract symptoms and Benign prostatic hyperplasia (LUTS/BPH)»? Is there a link between the two entities? What is the treatment of men with the two conditions simultaneously? Two medications or one for both?

Erectile Dysfunction: Introduction Erectile dysfunction (ED) is characterized by the consistent inability to attain or maintain an erection sufficient for satisfactory sexual intercourse 1 ED often 2-4 : Reduces motivation for sexual activity Creates a conscious focus on ED by the affected man Inhibits partner initiation of sexual activity 1. NIH Consensus Conference. JAMA 1993;270(1):83-90. 2. Perelman M et al. J Sex Med 2005;2:397-406. 3. Fisher W et al. J Sex Med 2005;2:675-84. 4. Cameron A et al. J Sex Marital Ther 2005;31:229-42.

Erectile dysfunction: Causes Male sexual arousal is a complex process that involves the brain, hormones, emotions, nerves, muscles and blood vessels. ED can result from a problem with any of these. Likewise, stress and mental health problems can cause or worsen ED. Sometimes a combination of physical and psychological issues causes erectile dysfunction.

Erectile dysfunction: Consequences An unsatisfactory sex life Stress or anxiety Embarrassment or low self-esteem Marital or relationship problems Inability to get your partner pregnant

Erectile dysfunction: Treatment Check medications that could be causing or worsening ED (Ex. Beta Blockers.) Lifestyle change (Alcohol, Tobacco) Improve communication with the partner and consider couples or marriage counseling.

Erectile dysfunction: Treatment Phosphodiesterase inhibitors (PDE5I): The only oral drugs approved for use in ED Intracavernous injections of papaverine and Prostaglandin Intraurethral prostaglandin Penile prosthesis

Mechanism of erection Anatomy of the penis

Mechanism of erection Role of GMPc

Mechanism of erection Role of PDE5

Mechanism of erection Role of PDE5 Inhibitors

The central role of Nitric Oxide (NO) in erectile function Cavernous nerve Adrenergic fibres Norepinephrine p Non-adrenergic non-cholinergic fibres Cholinergic fibres Acetylcholine SMC CONTRACTION RELAXATION SMC (corpus cavernosum) NO SMC (local arteries) Endothelial cell RELAXATION BLOOD INFLOW Engorgement of sinusoidal spaces NO, nitric oxide SMC, smooth muscle cells INTRACAVERNOUS PRESSURE ERECTION VENOUS COMPRESSION ( BLOOD OUTFLOW) Dean RC, Lue TF. Urol Clin North Am. 2005;32(4):379-v.

How does Nitric Oxide (NO) affect smooth muscle cell relaxation? NO-cGMP signaling pathway causes a decrease in cytosolic Ca 2+ that directly leads to SMC Relaxation. Regulated by phospodiesterase-5 (PDE-5) breakdown of cgmp. cgmp, cyclic guanosine monophosphate GTP, guanosine triphosphate NO, nitric oxide PDE-5, phospodiesterase-5 SMC, smooth muscle cell Dean RC, Lue TF. Urol Clin North Am. 2005;32(4):379-v.

Mechanism of action of PDE5I

Tadalafil 20mg: What s beyond the 36 hours efficacy?

Tadalafil 20mg Men with ED were randomized to Tadalafil 20mg (n=1143) and placebo (n=538)

Do patients use the 36 hour window offered by tadalafil? Tadalafil 20mg

Tadalafil Men who reported successful intercourse with tadalafil were significantly more satisfied with the hardness of their erection than men who reported successful intercourse with Placebo

Why the Once-Daily Option Oral PDE5 inhibitors successfully treat ED 1 ; however, Ameliorating the full psychological impact of ED remains a challenge 2 One complication is the lack of a clear pattern of timing of sexual activity for many couples 2 Once-daily dosing would offer an alternative for couples who prefer spontaneous instead of scheduled sexual activities, or for those who anticipate frequent sexual activities 1. Eardley I et al. J Sex Med 2010;7:524-40. 2. Fisher W et al. J Sex Med 2005;2:675-84.

tadalafil tadalafil

LUTS/BPH: Definition LUTS: obstructive and/or irritative symptoms May be secondary to prostatic obstruction or bladder problems Prostatic obstruction is due to Benign prostatic hyperplasia (BPH) LUTS/BPH is the right nomination

Link between ED and BPH-LUTS

Relationship between comorbidities and ED Cross-sectional study of men (n=2,476) aged 25 to 70 years in Spain Martin-Morales A, et al. J Urol. 2001;166(2):569-74.

LUTS severity correlates with the rate of ED Multinational Survey of the Aging Male (MSAM-7) in men (n=12,815) aged 50 to 80 years (US & EU) 100 90 80 70 60 50 40 30 20 10 0 LUTS Severity Frequency (%) Age Cohort Association between increased severity of LUTS, rate of ED and age Base: Total sample 14 12 2 27 25 50 45 2 5 70 53 40 17 33 49 43 7 6 65 53 83 83 50 59 years 60 69 years 70 79 years 12 64 19 57 41 16 70 50 20 52 31 89 45 44 Net reduction of stiffness No, I cannot get an erection Rosen R, et al. Eur Urol. 2003;44(6):637-49.

The role of Nitric Oxide (NO) in the lower urinary tract Prostate, urethra and bladder neck: Densely supplied by nitric i oxide (NO)-synthase-containing i nerves 1 In the bladder and urethra: NO relaxes smooth muscle of the bladder neck and urethra during voiding 2,3 May also potentiate detrusor contraction during micturition 3 May also control afferent activity in the outlet region 2 In the prostate: NO regulates prostate smooth muscle tone 4 Also regulates local l blood flow 4 1. Hedland P. World J Urol. 2005;23(6):362-7. 2. Andersson KE, Persson K. Scand J Urol Nephrol Suppl. 1995;175:43-53. 3. Kajioka S, et al. Cell Calcium. 2008;44(2):202-9. 4. Kedia GT, et al. World J Urol. 2008;26:603-9.

Strong epidemiological evidence supports a link between BPH-LUTS and ED A number of pathophysiological mechanisms are common to both conditions The nitric oxide/cyclic guanosine monophosphate h (NO/cGMP) signalling pathway has been widely implicated

The NO-cGMP pathway, with its action on smooth muscle tone, plays a central role in ED and is also involved in various aspects of LUT function this pathway is regulated by phosphodiesterase enzymes (PDE), providing a target for treatment with PDE-5 inhibitors Gacci M, et al. Eur Urol. 2011;60(4):809-25.

New approach to BPH-LUTS/ED In patients presenting with BPH-LUTS In patients presenting with ED Proactively inquire about co-morbid ED Proactively inquire about co-morbid LUTS The presence of co morbid BPH LUTS and ED has important implications on how each are managed Enables a comprehensive and integrated management plan to be developed May be jointly addressed d with combination drug therapy or single specific therapy Chitale S, et al. JSex Med. 2007;4:1713 25.

20. Egerdie RB, et al. J Sex Med 2012; 9(1): 271 281

20. Egerdie RB, et al. J Sex Med 2012; 9(1): 271 281

European association of Urology Guidelines 2014 PDE5I in LUTS/BPH PDE5I reduce moderate-to-severe (storage and voiding) LUTS in men with or without erectile dysfunction ((Grade A recommandation) Only tadalafil (5 mg once daily) hasbeenlicensedfor y g y the treatment of male LUTS.

Tadalafil: Safety profile

ELaC1

Slide 39 ELaC1 remove reference 2 and 3 remove AEs after myalgia Eli Lilly and Company, 18/06/2012

Take home message With concomitant BPH-LUTS and ED, consider the effects of treatments on each of these conditions. Recent experimental and clinical data point to a role for PDE5I inhibitors inbph-lus. PDE5 inhibitor monotherapy may improve LUTS while also treating concomitant ED. PDE5 i hibit th i ED hil PDE5 inhibitor monotherapy may improve ED while also treating concomitant LUTS.

Take home message What should I advise my patients while dispensing a prescription of Tadalafil 5mg? Take tadalafil 5mg orally, once a day, at approximately the same time each day with or without food. A response to ED can be observed within 5 days of once a day dosing as this is when steady-state plasma concentrations are attained. Tadalafil has been shown to improve urinary symptoms as early as 1-2 weeks after commencing treatment. Seftel A. et al. zed, J Urol. 2011 Jan; 185(1):243-8

10. Carson CC, et al. BJU Int. 2004;93:1276 1281. 14. Cialis spc

FAQs What are the most common side effects of tadalafil? A. Headache, dyspepsia, ypp back pain B. Headache, flushing, back pain C. Headache, dyspepsia, flushing D. Nausea, dyspepsia, back pain

FAQs What should I advise my patients t while dispensing i a prescription of tadalafil 20mg? A. Take tadalafil 20mg orally at any time with or without food B. You should have coverage from 30minutes post dose up to 36 hours. C. Remember that Sexual stimulation is required for you to obtain an erection. D. All of the above

FAQs What should I advise my patients while dispensing a prescription of Tadalafil 5mg? A. Take tadalafil 5mg orally, once a day, at approximately the same time each day with or without food. B. A response to ED can be observed within 5 days of once a day dosing as this is when steady-state plasma concentrations are attained. C. Tadalafil has been shown to improve urinary symptoms as early as 1-2 weeks after commencing treatment. D. All of the above

Thank You